ZAINAB BUNDU: Open Payments
NPI 1508384116 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 9 payments from 3 companies in 2025. Trend: 2023 $444 · 2024 $294 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 7 | $152 |
| Abbott Laboratories | 1 | $20 |
| Valinor Pharma, LLC | 1 | $17 |
Products named: XTAMPZA, Belbuca, ETERNA, MOVANTIK.
Industry payments across MD — which companies pay providers there.
